Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study
CONCLUSION: Therefore, in the PIs era, transplantations are still effective therapies for transplant-eligible MM patients.PMID:38205814 | DOI:10.1080/16078454.2023.2293579
Source: Hematology - Category: Hematology Authors: Linquan Zhan Dai Yuan Xueling Ge Mei Ding Jianhong Wang Xiangxiang Zhou Xin Wang Source Type: research
More News: Cancer & Oncology | Genetics | Hematology | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants